ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China flag China · Delayed Price · Currency is CNY
12.80
-0.45 (-3.40%)
At close: Nov 17, 2026

SHE:301017 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,6571,2411,4051,3971,860622.06
Trading Asset Securities
---100.07-121.42
Cash & Short-Term Investments
1,6571,2411,4051,4981,860743.47
Cash Growth
22.15%-11.69%-6.20%-19.50%150.23%31.79%
Accounts Receivable
1,1501,0961,3131,346896.39462.04
Other Receivables
290.58313.38191.0449.1833.8444.23
Receivables
1,4411,4101,5041,395930.24506.27
Inventory
1,8501,8931,8912,0681,7941,226
Prepaid Expenses
-0.830.530.35--
Other Current Assets
521.99475.56520.91549.6388.23254.2
Total Current Assets
5,4705,0205,3215,5114,9722,730
Property, Plant & Equipment
1,2251,3271,4251,4271,2571,025
Long-Term Investments
192.93206.49232.3225.03258.25225.81
Goodwill
2,3042,2641,7531,387975.06667.24
Other Intangible Assets
144.94147.75130.13128.18111.5168.92
Long-Term Deferred Tax Assets
158.45136.18164.2483.0652.8848.6
Long-Term Deferred Charges
97.7694.2997.23116.46102.6668.44
Other Long-Term Assets
209.42211.51150.56455.86133.07167.83
Total Assets
9,8029,4089,2739,3347,8635,003

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
3,6153,1462,5101,8981,7771,021
Accrued Expenses
103.8150.26139.61152.73159.895.75
Short-Term Debt
1,198869.481,6851,6311,210550.79
Current Portion of Long-Term Debt
588.1428.72232.24144.5551.7710.64
Current Portion of Leases
-332.26377.74425.68337.31242.21
Current Income Taxes Payable
52.9554.6357.4433.1956.4220.62
Current Unearned Revenue
53.265.2575.9891.468.5727.96
Other Current Liabilities
480.13500.45284.83887.02545.63653.6
Total Current Liabilities
6,0915,5475,3625,2644,2062,623
Long-Term Debt
1,1721,1931,3411,338988.28162.44
Long-Term Leases
263.21341.38410.75333.91374.68270.16
Long-Term Unearned Revenue
17.0917.3311.1411.4312.2713.11
Long-Term Deferred Tax Liabilities
5.5614.9422.8819.7314.4710.78
Other Long-Term Liabilities
---0.75-9.26
Total Liabilities
7,5487,1147,1486,9675,5963,089

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
405.61405.36405.35405.34405.34405.34
Additional Paid-In Capital
765.65800.81831.55831.33856.99857.19
Retained Earnings
822.21818.65704.42913.35826.9627.06
Treasury Stock
---42.97---
Comprehensive Income & Other
105.57106.06142.01142.05142.05-
Total Common Equity
2,0992,1312,0402,2922,2311,890
Minority Interest
155.03162.5584.774.1735.7924.45
Shareholders' Equity
2,2542,2932,1252,3662,2671,914
Total Liabilities & Equity
9,8029,4089,2739,3347,8635,003

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
3,2213,1654,0463,8732,9621,236
Net Cash (Debt)
-1,564-1,925-2,641-2,376-1,102-492.77
Net Cash Growth
------
Net Cash Per Share
-3.62-4.72-6.58-5.89-2.74-1.29
Filing Date Shares Outstanding
405.61405.61402.36405.34405.34405.34
Total Common Shares Outstanding
405.61405.36402.36405.34405.34405.34
Working Capital
-620.91-527.34-41.32246.84766.05107.45
Book Value Per Share
4.915.004.725.305.154.66
Tangible Book Value
-350.05-281.32157.73776.711,1451,153
Tangible Book Value Per Share
-1.12-0.960.041.572.472.85
Buildings
-725.67538.31415.79412.23369.65
Machinery
-362.94301.19246.47201.96164.94
Construction In Progress
-79.24162.87145.5925.6122.61